Literature DB >> 24228614

Metabolic mechanisms of epigenetic regulation.

Jordan L Meier1.   

Abstract

Chromatin modifications have been well-established to play a critical role in the regulation of genome function. Many of these modifications are introduced and removed by enzymes that utilize cofactors derived from primary metabolism. Recently, it has been shown that endogenous cofactors and metabolites can regulate the activity of chromatin-modifying enzymes, providing a direct link between the metabolic state of the cell and epigenetics. Here we review metabolic mechanisms of epigenetic regulation with an emphasis on their role in cancer. Focusing on three core mechanisms, we detail and draw parallels between metabolic and chemical strategies to modulate epigenetic signaling, and highlight opportunities for chemical biologists to help shape our knowledge of this emerging phenomenon. Continuing to integrate our understanding of metabolic and genomic regulatory mechanisms may help elucidate the role of nutrition in diseases such as cancer, while also providing a basis for new approaches to modulate epigenetic signaling for therapeutic benefit.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 24228614      PMCID: PMC3918459          DOI: 10.1021/cb400689r

Source DB:  PubMed          Journal:  ACS Chem Biol        ISSN: 1554-8929            Impact factor:   5.100


  155 in total

Review 1.  Mechanism-based profiling of enzyme families.

Authors:  Michael J Evans; Benjamin F Cravatt
Journal:  Chem Rev       Date:  2006-08       Impact factor: 60.622

2.  Dynamics and memory of heterochromatin in living cells.

Authors:  Nathaniel A Hathaway; Oliver Bell; Courtney Hodges; Erik L Miller; Dana S Neel; Gerald R Crabtree
Journal:  Cell       Date:  2012-06-14       Impact factor: 41.582

3.  Methionine adenosyltransferase II serves as a transcriptional corepressor of Maf oncoprotein.

Authors:  Yasutake Katoh; Tsuyoshi Ikura; Yutaka Hoshikawa; Satoshi Tashiro; Takashi Ito; Mineto Ohta; Yohei Kera; Tetsuo Noda; Kazuhiko Igarashi
Journal:  Mol Cell       Date:  2011-03-04       Impact factor: 17.970

Review 4.  Lessons from the cancer genome.

Authors:  Levi A Garraway; Eric S Lander
Journal:  Cell       Date:  2013-03-28       Impact factor: 41.582

5.  Identification of nicotinamide N-methyltransferase as a novel serum tumor marker for colorectal cancer.

Authors:  Markus Roessler; Wolfgang Rollinger; Stefan Palme; Marie-Luise Hagmann; Peter Berndt; Alfred M Engel; Bernd Schneidinger; Michael Pfeffer; Herbert Andres; Johann Karl; Heinz Bodenmüller; Josef Rüschoff; Thomas Henkel; Gerhard Rohr; Siegbert Rossol; Wolfgang Rösch; Hanno Langen; Werner Zolg; Michael Tacke
Journal:  Clin Cancer Res       Date:  2005-09-15       Impact factor: 12.531

6.  ATP citrate lyase inhibition can suppress tumor cell growth.

Authors:  Georgia Hatzivassiliou; Fangping Zhao; Daniel E Bauer; Charalambos Andreadis; Anthony N Shaw; Dashyant Dhanak; Sunil R Hingorani; David A Tuveson; Craig B Thompson
Journal:  Cancer Cell       Date:  2005-10       Impact factor: 31.743

7.  Metabolomic profiles delineate potential role for sarcosine in prostate cancer progression.

Authors:  Arun Sreekumar; Laila M Poisson; Thekkelnaycke M Rajendiran; Amjad P Khan; Qi Cao; Jindan Yu; Bharathi Laxman; Rohit Mehra; Robert J Lonigro; Yong Li; Mukesh K Nyati; Aarif Ahsan; Shanker Kalyana-Sundaram; Bo Han; Xuhong Cao; Jaeman Byun; Gilbert S Omenn; Debashis Ghosh; Subramaniam Pennathur; Danny C Alexander; Alvin Berger; Jeffrey R Shuster; John T Wei; Sooryanarayana Varambally; Christopher Beecher; Arul M Chinnaiyan
Journal:  Nature       Date:  2009-02-12       Impact factor: 49.962

8.  Glioma-derived mutations in IDH1 dominantly inhibit IDH1 catalytic activity and induce HIF-1alpha.

Authors:  Shimin Zhao; Yan Lin; Wei Xu; Wenqing Jiang; Zhengyu Zha; Pu Wang; Wei Yu; Zhiqiang Li; Lingling Gong; Yingjie Peng; Jianping Ding; Qunying Lei; Kun-Liang Guan; Yue Xiong
Journal:  Science       Date:  2009-04-10       Impact factor: 47.728

9.  An inhibitor of mutant IDH1 delays growth and promotes differentiation of glioma cells.

Authors:  Dan Rohle; Janeta Popovici-Muller; Nicolaos Palaskas; Sevin Turcan; Christian Grommes; Carl Campos; Jennifer Tsoi; Owen Clark; Barbara Oldrini; Evangelia Komisopoulou; Kaiko Kunii; Alicia Pedraza; Stefanie Schalm; Lee Silverman; Alexandra Miller; Fang Wang; Hua Yang; Yue Chen; Andrew Kernytsky; Marc K Rosenblum; Wei Liu; Scott A Biller; Shinsan M Su; Cameron W Brennan; Timothy A Chan; Thomas G Graeber; Katharine E Yen; Ingo K Mellinghoff
Journal:  Science       Date:  2013-04-04       Impact factor: 47.728

10.  Oncometabolite 2-hydroxyglutarate is a competitive inhibitor of α-ketoglutarate-dependent dioxygenases.

Authors:  Wei Xu; Hui Yang; Ying Liu; Ying Yang; Ping Wang; Se-Hee Kim; Shinsuke Ito; Chen Yang; Pu Wang; Meng-Tao Xiao; Li-xia Liu; Wen-qing Jiang; Jing Liu; Jin-ye Zhang; Bin Wang; Stephen Frye; Yi Zhang; Yan-hui Xu; Qun-ying Lei; Kun-Liang Guan; Shi-min Zhao; Yue Xiong
Journal:  Cancer Cell       Date:  2011-01-18       Impact factor: 38.585

View more
  26 in total

Review 1.  Touch, act and go: landing and operating on nucleosomes.

Authors:  Valentina Speranzini; Simona Pilotto; Titia K Sixma; Andrea Mattevi
Journal:  EMBO J       Date:  2016-01-19       Impact factor: 11.598

Review 2.  Metabolic control of epigenetics in cancer.

Authors:  Adam Kinnaird; Steven Zhao; Kathryn E Wellen; Evangelos D Michelakis
Journal:  Nat Rev Cancer       Date:  2016-09-16       Impact factor: 60.716

3.  Intracellular crotonyl-CoA stimulates transcription through p300-catalyzed histone crotonylation.

Authors:  Benjamin R Sabari; Zhanyun Tang; He Huang; Vladimir Yong-Gonzalez; Henrik Molina; Ha Eun Kong; Lunzhi Dai; Miho Shimada; Justin R Cross; Yingming Zhao; Robert G Roeder; C David Allis
Journal:  Mol Cell       Date:  2015-03-26       Impact factor: 17.970

Review 4.  Epigenetic regulation by endogenous metabolite pharmacology.

Authors:  Rhushikesh A Kulkarni; David C Montgomery; Jordan L Meier
Journal:  Curr Opin Chem Biol       Date:  2019-03-15       Impact factor: 8.822

5.  Impact of a High-fat Diet on Tissue Acyl-CoA and Histone Acetylation Levels.

Authors:  Alessandro Carrer; Joshua L D Parris; Sophie Trefely; Ryan A Henry; David C Montgomery; AnnMarie Torres; John M Viola; Yin-Ming Kuo; Ian A Blair; Jordan L Meier; Andrew J Andrews; Nathaniel W Snyder; Kathryn E Wellen
Journal:  J Biol Chem       Date:  2017-01-11       Impact factor: 5.157

Review 6.  Nutrition, the brain and cognitive decline: insights from epigenetics.

Authors:  M J Dauncey
Journal:  Eur J Clin Nutr       Date:  2014-09-03       Impact factor: 4.016

7.  Nucleotide resolution sequencing of N4-acetylcytidine in RNA.

Authors:  Justin M Thomas; Keri M Bryson; Jordan L Meier
Journal:  Methods Enzymol       Date:  2019-03-12       Impact factor: 1.600

8.  Heterogeneous adaptation of cysteine reactivity to a covalent oncometabolite.

Authors:  Minervo Perez; Daniel W Bak; Sarah E Bergholtz; Daniel R Crooks; Bhargav Srinivas Arimilli; Youfeng Yang; Eranthie Weerapana; W Marston Linehan; Jordan L Meier
Journal:  J Biol Chem       Date:  2020-08-19       Impact factor: 5.157

9.  Metformin targets histone acetylation in cancer-prone epithelial cells.

Authors:  Elisabet Cuyàs; Salvador Fernández-Arroyo; Jorge Joven; Javier A Menendez
Journal:  Cell Cycle       Date:  2016-10-28       Impact factor: 4.534

10.  Photoinducible Oncometabolite Detection.

Authors:  Rhushikesh A Kulkarni; Chloe A Briney; Daniel R Crooks; Sarah E Bergholtz; Chandrasekhar Mushti; Stephen J Lockett; Andrew N Lane; Teresa W-M Fan; Rolf E Swenson; W Marston Linehan; Jordan L Meier
Journal:  Chembiochem       Date:  2018-12-13       Impact factor: 3.164

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.